Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sep 30, 2011


Applied Biomics this week added Isobaric Tags for Relative and Absolute Quantitation, or iTRAQ, services to its line of proteomics offerings.

The technique enables identification and quantification of proteins and peptides in a single experiment via MS/MS analysis. The company is guaranteeing turnaround of iTRAQ orders within a week.

Origene this week announced the availability of new conjugated anti-DDK antibodies for the detection and purification of recombinant antibodies.

The new antibodies include: Anti-DDK mouse mAb and Anti-DDK-HRP for Western blotting; Anti-DDK-DyLight 488/550 for detection via immunofluorescent staining; Anti-DDK-phycoerythrin for cell sorting by flow cytometry; and Anti-DDK-biotin for protein purification and immunoprecipitation.

Silicon Kinetics has released SKi Bridge, a fluidic interface for affinity capture-mass spec.

The company said that the interface enables AC-MS by allowing only molecules with desired binding/release profiles to be eluted into a mass spectrometer.

According to the firm, AC-MS “combines the sensitivity of label-free interaction analysis with the information richness of mass spectroscopy, in a fully in-line setup, useable up to 15,000 psi.”

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.